VTRS
$VTRS
Viatris Inc.
Global pharmaceutical company formed from Mylan and Pfizer Upjohn merger making generic and branded drugs.
Healthcare$19.04
-0.17 (-0.86%)
Day Range$19.00 - $19.50
Prev Close$19.20
Analyst Rating
Buy
7 Buy / 4 Hold / 1 Sell
Price Target
$21.00
10.3% upside
Subscribers
0
Tracking this ticker
Latest Report
Analysis from Oct 30, 2026
VTRS: Pacira Deal, Earnings & Valuation
Viatris is trading near its 52 week high heading into an earnings report and a major tender offer for Pacira. Analysts are broadly positive, but leverage and integration risk temper the outlook.
Oct 31, 2026
Previous Reports
Keep exploring
- draft Viatris into a free practice contest: How to put the stock you just researched into a contest lineup at no real-money risk
- the healthcare sector brief for context on Viatris's peers: Today's sector-level news and moves around the stock